Quantum Cyber N.V. Other Expense By Function
Quantum Cyber N.V. (QUCY) reported Other Expense By Function of $134.60 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-10-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherExpenseByFunction · last filed 2024-10-18
- Quantum Cyber N.V. other expense by function for the quarter ending 2023-09-30 was $697.77K, a 251.14% increase year-over-year.
- Quantum Cyber N.V. other expense by function for the quarter ending 2023-06-30 was $432.78K, a 5050.30% increase year-over-year.
- Quantum Cyber N.V. other expense by function for the quarter ending 2022-09-30 was $198.72K.
- Quantum Cyber N.V. other expense by function for the quarter ending 2022-06-30 was $8.40K.
| Period end | Other Expense By Function 3 month | Other Expense By Function 6 month | Other Expense By Function 6 month as first filed | Other Expense By Function 9 month |
|---|---|---|---|---|
| 2024-06-30 | $134.60K 6-K · filed 2024-10-18 | |||
| 2023-09-30 | $697.77K 6-K · filed 2023-11-16 | $1.13M derived: sum of 2 quarters · filed 2023-11-16 | $1.27M 6-K · filed 2023-11-16 | |
| 2023-06-30 | $432.78K 6-K · filed 2023-08-15 | $231.21K 6-K · filed 2024-10-18 | $569.97K 6-K · filed 2023-08-15 | |
| 2022-09-30 | $198.72K 6-K · filed 2023-11-16 | $207.12K derived: sum of 2 quarters · filed 2023-11-16 | $314.63K 6-K · filed 2023-11-16 | |
| 2022-06-30 | $8.40K 6-K · filed 2023-08-15 | $115.91K 6-K · filed 2023-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |